Nirogacestat (Ogsiveo) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)

This PQI in Action is a follow up to the Positive Quality Intervention: Nirogacestat (OGSIVEO®) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis) PQI and explores how the medically integrated teams at American Oncology Network (AON), Northwell Health, and Texas Oncology collaborate and utilize the information found in the PQI as part of their daily practice.